Skip to content
  • Saturday, 12 September 2026
  • 6:38 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease
Pharmaceutical R&D

Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease

Teuku Ryan Jul 24, 2026 0

Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…

Read More
Laboratory Automation & Robotics

Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases

Lana Keisha Apr 6, 2026 0

An ambitious new international collaboration, bolstered by a prestigious pan-European EUREKA grant, is set to revolutionize the treatment landscape for…

Read More
Laboratory Automation & Robotics

Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases

Lana Keisha Mar 29, 2026 0

A groundbreaking international collaboration, fortified by a prestigious pan-European EUREKA grant, has been officially launched to pioneer the development of…

Read More
Laboratory Automation & Robotics

Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases

Lana Keisha Mar 22, 2026 0

A groundbreaking international collaboration, bolstered by a prestigious pan-European EUREKA grant, has been officially announced, aiming to pioneer the development…

Read More
American Diabetes Association Conference Sees Landmark GLP-1 Trial Results Amidst Unprecedented Controversy Over Researcher RemovalINTEGRA Biosciences Automates Quantabio sparQ DNA Frag & Library Prep Kit Workflow, Enhancing NGS Efficiency and ReproducibilityFirst Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?The Ancient Story of Every Breath Revealed in 289-Million-Year-Old Fossil
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
The oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ